Letters to the Editor

Letters to the Editor are no longer included in the main BJUI journal, but we will continue to publish them on the BJUI website as an important part of the scientific debate.

Letters Policy

  • Letters to the editor will now published in electronic form on the journal website (www.bjuinternational.com), not in the journal itself. As such, letters are not submitted to PubMed for indexing.
  • Letters to the editor should be 500 words or less, preference is given to concise letters.
  • Writers are limited to one letter published on the website per month.
  • Letters must include full author contact details.
  • All letters will be peer-reviewed, and we reserve the right to reject letters, or to edit them if they are accepted.
  • If accepted, letters are sent to the authors of the paper being discussed, to give them the chance to make a response that will (if accepted) be published at the same time as the letter.
  • Letters will not be open for public comment; replies must be submitted by email to the Editorial Office for review.

Re: Millin’s prostatectomy in the era of ‘Getting It Right First Time’ and Montgomery: exploring variation in clinical practice and consent

/
Letter to the Editor Millin’s prostatectomy in the era of ‘Get it Right First Time’ and Montgomery: exploring variation in clinical practice and consent. We read with interest the comment in last months BJUI where it was suggested that the Millin retropubic simple prostatectomy for BPH should be confined to history in part because of the Montgomery ruling and the GIRFT programme [1]. GIRFT was designed to identify variations and raise standards of care. The urology report has since been…

Re: Use of 5α-reductase inhibitors for BPH and risk of high-grade PCa: A French population-based study

Letter to the Editor Re: Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high-grade prostate cancer: A French population-based study Sir, We read with interest the article entitled “Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high-grade prostate cancer: A French population-based study” by Scailteux et al. [1]. We appreciate that patients should be informed about the high-grade disease that can develop in patients treated with…

Re: Efficacy and safety of PAE for BPH: an observational study and propensity-matched comparison with TUR of the prostate (the UK- ROPE study)

Letter to the Editor Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK- ROPE study) Sir, We read the manuscript by Ray and colleagues and congratulate the authors for the effort spent on this remarkable work. To date, this is the first large multicentre study to assess and compare the efficacy and safety of prostate artery embolization (PAE) for…

Re: Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study

Letter to the Editor Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study Sir, We read the article by Su et al describing a new and innovative Zhu‘s transurethral port for performing transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy [1]. We appreciate the authors’ innovation in making LESS urological surgery feasible and simplifying the technically demanding lower tract…

Re: Anomalous observations with regard to prostate cancer research

Letter to the Editor Anomalous observations with regard to prostate cancer research Sir, The article “Anomalous observations with regard to prostate cancer research” [1] was very interesting and informative and I actually agree with all the points raised in that article. Another important observation which may affect the relationship or association between metabolic syndrome (MetS ) and prostate cancer,  is the definition of MetS that is utilized in the various studies. For instance,…
© 2020 BJU International. All Rights Reserved.